The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonnard, M.
Right arrow Articles by Julius, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnard, M.
Right arrow Articles by Julius, M.
The Journal of Immunology, 1999, 162: 1252-1260.
Copyright © 1999 by The American Association of Immunologists

CD4-Mediated Inhibiton of IL-2 Production in Activated T Cells1

Madeleine Bonnard*, Loralee Haughn{dagger} and Michael Julius2,*

* Department of Immunology, University of Toronto, Toronto, Ontario, Canada, and Arthritis and Immune Disorder Research Centre, The Toronto Hospital, Toronto, Ontario, Canada; and {dagger} Division of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109

The role of CD4 in T cell activation has been attributed to its capacity to increase the avidity of interaction with APC and to shuttle associated Lck to the TCR/CD3 activation complex. The results presented in this study demonstrate that ligation of CD4 inhibits ongoing responses of preactivated T cells. Specifically, delayed addition of CD4-specific mAb is shown to inhibit Ag- or mAb-induced responses of both primary T cells and T cell clonal variants. The Ag responses of the latter are independent of the adhesion provided by CD4; thus the observed inhibition is not due to blocking CD4-MHC interactions. Further, analysis of the clonal variants demonstrates that CD4-associated Lck is not essential for the inhibition observed, as anti-CD4 inhibits responses of clonal variants, expressing a form of CD4 unable to associate with Lck (double cysteine-mutated CD4). The inhibition is counteracted by the addition of exogenous IL-2, demonstrating that the block is not due to a lesion in IL-2 utilization, rather its production. It is demonstrated that the delayed addition of anti-CD4 results in a rapid reduction in steady-state levels of IL-2 mRNA in both primary T cells and clonal variants.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Fragoso, D. Ren, X. Zhang, M. W.-C. Su, S. J. Burakoff, and Y.-J. Jin
Lipid Raft Distribution of CD4 Depends on its Palmitoylation and Association with Lck, and Evidence for CD4-Induced Lipid Raft Aggregation as an Additional Mechanism to Enhance CD3 Signaling
J. Immunol., January 15, 2003; 170(2): 913 - 921.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Harding, P. Lipp, and D. R. Alexander
A Therapeutic CD4 Monoclonal Antibody Inhibits TCR-{zeta} Chain Phosphorylation, {zeta}-Associated Protein of 70-kDa Tyr319 Phosphorylation, and TCR Internalization in Primary Human T Cells
J. Immunol., July 1, 2002; 169(1): 230 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Thebault, F. Gachon, I. Lemasson, C. Devaux, and J.-M. Mesnard
Molecular Cloning of a Novel Human I-mfa Domain-containing Protein That Differently Regulates Human T-cell Leukemia Virus Type I and HIV-1 Expression
J. Biol. Chem., February 18, 2000; 275(7): 4848 - 4857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zeitlmann, P. Sirim, E. Kremmer, and W. Kolanus
Cloning of ACP33 as a Novel Intracellular Ligand of CD4
J. Biol. Chem., March 16, 2001; 276(12): 9123 - 9132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.